Subscribe
A worldwide window to Cambridge business, innovation and technology
Quantum leap: Oxford hails advent of fault-tolerant quantum computers

Quantum leap: Oxford hails advent of fault-tolerant quantum computers

Research steered by Oxford University has triggered a powerful new technique to find the nextgen materials needed for large-scale, fault-tolerant quantum computing.
Cambridge R&D Centre being created by BioNTech in £1bn UK spree

Cambridge R&D Centre being created by BioNTech in £1bn UK spree

Cambridge has been hand-picked by German immunotherapy powerhouse BioNTech to house a new R&D hub as part of a potential £1 billion 10-year investment programme in the UK, creating hundreds of jobs.
Cambridge VC investment surges to $2.3bn as science-led innovation soars

Cambridge VC investment surges to $2.3bn as science-led innovation soars

Cambridge startups and scaleups raised $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion. The figures highlight that science-led innovation in the city is not slowing down anytime soon, according to new analysis by Dealroom for Founders at the University of Cambridge.
Cambridge-US arrow flies straight to the heart of nextgen entrepreneurship

Cambridge-US arrow flies straight to the heart of nextgen entrepreneurship

Vellos – a company founded by the Director of the Milner Therapeutics Institute at the University of Cambridge, Professor Sir Tony Kouzarides – has announced a new partnership with Fifty Years, a renowned pre-seed and seed focused VC firm based in Silicon Valley.
CellCentric raises $120m from global backers to advance drug for multiple myeloma

CellCentric raises $120m from global backers to advance drug for multiple myeloma

Cambridge life science company CellCentric has raised $120 million Series C financing to advance its fight against an insidious form of cancer. CellCentric plans to use the proceeds to further support, among other missions, the advancement of its novel oral p300/CBP inhibitor, inobrodib, intro registration studies.
Academia
Sharewatch
Manufacturing
University of Oxford spin-out NavLive raises £4m
02 Jun 2025 - 12:00
ARIA hits high notes as Universities orchestrate £62.4m 'food of the future' project
02 Jun 2025 - 12:00
British Antarctic Survey puts AI into ArctIc to aid caribou conservation
29 May 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

University of Oxford spin-out NavLive raises £4m

University of Oxford spin-out NavLive raises £4m

University of Oxford spin-out NavLive has officially launched after securing £4 million in combined investment and grant funding. The startup is working to improve how spatial data is captured and deployed across the built environment, according to CEO Chris Davison.
Marshall picks up the pace via Canada operations

Marshall picks up the pace via Canada operations

Cambridge-rooted Marshall is making huge strides with its Canadian enterprise – handsomely justifying its decision to set up a base there through establishing Marshall Canada.
ARIA hits high notes as Universities orchestrate £62.4m 'food of the future' project

ARIA hits high notes as Universities orchestrate £62.4m 'food of the future' project

Leading scientists from American, German and UK universities – notably Cambridge and Norwich – are working on the first phase of a major new Advanced Research and Invention Agency (ARIA) programme to help develop the plants and food of the future.
Howes Percival has a whale of a time as it toasts 10 years and growth in Cambridge

Howes Percival has a whale of a time as it toasts 10 years and growth in Cambridge

Law firm Howes Percival has moved to new premises to house its rapidly growing team and marked the 10th anniversary of its Cambridge office with a party for clients and contacts.
More news

Tech trail

University of Oxford spin-out NavLive raises £4m

University of Oxford spin-out NavLive raises £4m

University of Oxford spin-out NavLive has officially launched after securing £4 million in combined investment and grant funding. The startup is working to improve how spatial data is captured and deployed across the built environment, according to CEO Chris Davison.
Caps Cases boxes clever with expansion fuelled by £1.8m Lloyds deal

Caps Cases boxes clever with expansion fuelled by £1.8m Lloyds deal

A Newmarket manufacturer has invested in two new state-of-the-art machines to accelerate its growth and sustainability ambitions after clinching £1.8 million funding support from Lloyds.
Gates Foundation backs exciting Gene Weaver progress

Gates Foundation backs exciting Gene Weaver progress

Gene Weaver, a Cambridge Cluster biotech innovator, has received $515,214 from the Gates Foundation to support the development of a next generation gene insertion tool.
Sparxell wins €1.9m European grant as it raises cash to target $48bn market

Sparxell wins €1.9m European grant as it raises cash to target $48bn market

Cambridge University spin-out Sparxell is currently fundraising to accelerate market adoption of its sustainable colourant technology across fashion, cosmetics, as well as industrial applications such as paint and packaging.
More Tech trail

Trade floor

Marshall picks up the pace via Canada operations

Marshall picks up the pace via Canada operations

Cambridge-rooted Marshall is making huge strides with its Canadian enterprise – handsomely justifying its decision to set up a base there through establishing Marshall Canada.
Nuclera and Danaher-owned US ally boost protein proposition

Nuclera and Danaher-owned US ally boost protein proposition

Cambridge biotech Nuclera has agreed a collaboration with Danaher company and international life sciences leader Cytiva, which promises global traction.
First patient dosed in STORM-Coherus cancer alliance

First patient dosed in STORM-Coherus cancer alliance

STORM Therapeutics, a clinical stage Cambridge company pioneering cellular reprogramming through RNA modifications to treat disease, has dosed its first patient in a collaboration with California-based Coherus BioSciences, Inc.
Johnson Matthey shares rocket after $2.4bn sale of catalyst division to Honeywell

Johnson Matthey shares rocket after $2.4bn sale of catalyst division to Honeywell

Johnson Matthey Plc, which has major interests in the Cambridge Cluster, has sold its catalyst technologies business to Honeywell International for $2.4 billion (£1.8bn) on a cash and debt-free basis.
FocalPoint-STMicroelectronics alliance enhances autonomous vehicle safety

FocalPoint-STMicroelectronics alliance enhances autonomous vehicle safety

FocalPoint, a Cambridge software company providing nextgen positioning solutions for automotive, wearables and smartphones, has unveiled a strategic collaboration with STMicroelectronics, a global semiconductor leader.
More Trade floor